Showing 2,841 - 2,860 results of 4,404 for search '"Clinical trial"', query time: 0.07s Refine Results
  1. 2841

    Virtual reality technology improves the gait and balance function of the elderly: a meta-analysis of randomized controlled trials by Junyu Chen, Shuxia Yan, Haiyan Yin, Dan Lin, Ziqi Mei, Zichun Ding, Meng Wang, Yamei Bai, Guihua Xu

    Published 2024-07-01
    “…Material and methods Two authors independently searched EMBASE, PubMed, Web of Science, ClinicalTrials, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang and Weipu databases up to October 20, 2023 for randomized controlled trials (RCTs) on the application of VR in improving the gait and balance function in the elderly. …”
    Get full text
    Article
  2. 2842

    Comprehensive review of preclinical evaluation strategies for COVID-19 vaccine candidates: assessing immunogenicity, toxicology, and safety profiles by Delaram Doroud, Mojtaba Daneshi, Fatemeh Kazemi-Lomedash, Zohre Eftekhari

    Published 2025-02-01
    “…This guidance is essential for researchers and manufacturers to design effective vaccines that can progress to clinical trials safely. …”
    Get full text
    Article
  3. 2843

    How you ask matters: evidence-based assessment connecting decentering, reappraisal, and self-reported wellbeing in a post-secondary sample by Yiyi Wang, Joanne M. Chung, Norman A. S. Farb, Norman A. S. Farb

    Published 2025-01-01
    “…This research contributes not only to our understanding of Wellbeing, but also informs its optimal assessment in longitudinal research such as clinical trials and experience sampling studies.…”
    Get full text
    Article
  4. 2844
  5. 2845

    How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies by Sofia Miranda Fernandes, Johanna Mayer, Per Nilsson, Makoto Shimozawa

    Published 2025-01-01
    “…We accessed clinicaltrials.gov provided by the United States National Institutes of Health to identify completed and ongoing clinical trials. Additionally, we discuss the limitations and challenges of these therapies.…”
    Get full text
    Article
  6. 2846

    Lifestyle Factors in Hypertension Drug Research: Systematic Analysis of Articles in a Leading Cochrane Report by Dan E. Wilson, Tashina Van Vlack, Brendin P. Schievink, Eric B. Doak, Jason S. Shane, Elizabeth Dean

    Published 2014-01-01
    “…This study systematically reviewed the methodology of articles from a recent Cochrane review that had been designed to inform first-line medical treatment of hypertension and was representative of high quality established clinical trials in the field. Source articles (n=34) were systematically reviewed for lifestyle interventions including smoking cessation, diet, weight loss, physical activity and exercise, stress reduction, and moderate alcohol consumption. 54% of articles did not mention lifestyle modification; 46% contained nonspecific descriptions of interventions. …”
    Get full text
    Article
  7. 2847

    Unveiling the Emerging Role of Xanthine Oxidase in Acute Pancreatitis: Beyond Reactive Oxygen Species by Chenxia Han, Yaling Wu, Juan Rong, Qing Xia, Dan Du

    Published 2025-01-01
    “…This review summarized the benefits and contradictions of using XO inhibitors in animal models, offered mechanisms other than ROS, and discussed the difficulties faced in clinical trials. We hope to provide a perspective on the future worthwhile basic and clinical research on XO by analyzing its chemical and biological characteristics, as well as the progress of its regulatory mechanisms in AP.…”
    Get full text
    Article
  8. 2848

    C-28 linker length modulates the activity of second-generation HIV-1 maturation inhibitors by K. C. Yuvraj, Aradhana Singh, Sayantani Datta, Ritika Das, Pranjal Raj Saxena, Subash Chapagain, T. J. Nitz, Carl Wild, Ritu Gaur

    Published 2025-01-01
    “…Bevirimat (BVM), a first-in-class MI, displayed sub-optimal efficacy in clinical trials due to presence of SP1:V7A polymorphism in the Gag protein.This polymorphism is inherently present in HIV-1 subtype C and conferred resistance to BVM. …”
    Get full text
    Article
  9. 2849

    Comparative Analysis of the Efficiency of Medicinal Plants for the Treatment and Prevention of COVID-19 by Viktor Kamkin, Aidana Kamarova, Baurzhan Shalabayev, Assyltas Kussainov, Marat Anuarbekov, Serik Abeuov

    Published 2022-01-01
    “…It is advisable to conduct further clinical trials for the treatment and rehabilitation of COVID-19 using preparations from this plant.…”
    Get full text
    Article
  10. 2850

    Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma by Michela Roberto, Maria Bassanelli, Elsa Iannicelli, Silvana Giacinti, Chiara D’Antonio, Anna Maria Aschelter, Paolo Marchetti

    Published 2015-01-01
    “…However, validated treatment guidelines for RCC patients with brain metastases are not yet available on account of the frequent exclusion of such patients from clinical trials. Moreover, limited data about the sequential use of three therapies, changing the class of agent, have been published up to now. …”
    Get full text
    Article
  11. 2851

    Possible factors responsible for increased risk of tendon injuries during strength training in adult patients: systematic review by Zbigniew Wroński, Burim Gjinovci, Mario Klasic

    Published 2024-06-01
    “…Material and methods: A search was conducted in June and July 2023 in PubMed/Medline, EMBASE, Science Direct, PEDro, and Cochrane databases. Clinical trials, meta-analyses, randomized controlled trials, reviews, and systematic reviews published within the last ten years were included if they considered strength and resistance training as risk factors for tendon injuries. …”
    Get full text
    Article
  12. 2852

    Acute Putrescine Supplementation with Schwann Cell Implantation Improves Sensory and Serotonergic Axon Growth and Functional Recovery in Spinal Cord Injured Rats by J. Bryan Iorgulescu, Samik P. Patel, Jack Louro, Christian M. Andrade, Andre R. Sanchez, Damien D. Pearse

    Published 2015-01-01
    “…Schwann cell (SC) transplantation exhibits significant potential for spinal cord injury (SCI) repair and its use as a therapeutic modality has now progressed to clinical trials for subacute and chronic human SCI. Although SC implants provide a receptive environment for axonal regrowth and support functional recovery in a number of experimental SCI models, axonal regeneration is largely limited to local systems and the behavioral improvements are modest without additional combinatory approaches. …”
    Get full text
    Article
  13. 2853

    Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice by Marcela P. Cataldi, Qi L. Lu

    Published 2025-01-01
    “…Supplement of ribitol and ribose have been reported to increase the levels of CDP-ribitol in both cells and in muscles in vivo. Clinical trials with both ribitol and ribose have been reported for treating LGMD2I caused by mutations in the FKRP gene. …”
    Get full text
    Article
  14. 2854

    Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques by Shery Jacob, Fathima Sheik Kather, Sai H. S. Boddu, Mahesh Attimarad, Anroop B. Nair

    Published 2025-01-01
    “…This article summarizes key stabilizers, polymers, surfactants, and excipients used in NS formulations, along with ongoing clinical trials and recent patents. Furthermore, a comprehensive analysis of various methods for NS preparation is provided. …”
    Get full text
    Article
  15. 2855

    Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia by Yuri Sakai Ishizaki, Masao Kikuchi, Koichi Kaikita, Shouichi Fujimoto

    Published 2024-11-01
    “…SGLT2 inhibitors have demonstrated efficacy in suppressing CKD progression in clinical trials, but their mechanisms are not fully understood. …”
    Get full text
    Article
  16. 2856

    The Natural History of Pancreatic Cancer in Manitoba: A Population Based Study by Jack Martin, Brian H Weinerman

    Published 1992-01-01
    “…The poor prognosis of all individuals confirms the rationale of trying to develop better treatments for all stages of disease, and stage and pathological differentiation should be taken into account when designing clinical trials.…”
    Get full text
    Article
  17. 2857

    Design and Preparing a Topical Semi-solid Formulation of a Combination of Plantago ovata seeds and Rosehip oil to Provide an Analgesic and Anti-inflammatory Medicine by Amirhossein Zamani, Aida Alipour, Mohammad M. Zarshenas, Hajar Ashrafi

    Published 2024-12-01
    “…After passing the clinical trials, the mentioned product can be effective as a product derived from herbal compounds for pain control.…”
    Get full text
    Article
  18. 2858

    Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer by Riley J. Morrow, Nima Etemadi, Belinda Yeo, Matthias Ernst

    Published 2017-01-01
    “…While there are various novel treatment strategies already underway in clinical trials, the need for further development of preclinical models of this rare but aggressive disease is paramount.…”
    Get full text
    Article
  19. 2859

    Fine-tuning SLE treatment: the potential of selective TYK2 inhibition by Yoshiya Tanaka, Shingo Nakayamada, Yurie Satoh-Kanda

    Published 2024-12-01
    “…Although several JAK/TYK2 inhibitors are currently undergoing clinical trials, more selective drugs that can target cytokine signals according to the specific pathology of the disease are required. …”
    Get full text
    Article
  20. 2860

    GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes by María Isabel del Olmo-Garcia, Juan Francisco Merino-Torres

    Published 2018-01-01
    “…On the other hand, recent clinical trials aimed at studying cardiovascular episodes have been conducted with GLP-1 RAs. …”
    Get full text
    Article